Healthcare Acquires Betterpath Health

Princeton-based has acquired Betterpath, a Brooklyn-based company focused on improving patient access to healthcare data. The combined organization creates a powerful combination of consumer consent as a service, and healthcare’s untapped datasets. Patients empowered with consent via’s #My31 app for Apple and Android will be able to request deep clinical datasets from hospitals, clinics, and laboratories which are often still on paper, behind fax machines, unstructured and referred to by Andreessen Horowitz’s general partner Vijay Pande, as healthcare’s “Dark Data”.

Matt Sinderbrand, CEO and co-founder of Betterpath will join as Senior Vice President, Chief Product Officer as well as a member of the Board of Directors. “The track and trace of consent and authorization model that has brought to market has been what is missing in healthcare data from the inception,” states Sinderbrand. “The simple idea that we should put the consumer (the patient) into the center of the healthcare data supply chain with ownership rights literally at their fingertips is both powerful, and timely.”

Sinderbrand started Betterpath after experiencing first-hand his sister’s struggle with accessing her own healthcare data while battling Crohn’s disease, and as a result prioritized the training of Betterpath’s Lumos medical natural language understanding to learn more than 100,000 biomedical-terms, synonyms, relationships, and structured codes. In honor of his sister’s condition, the first disease vocabulary programmed was Inflammatory Bowel Disease.

“I’ve seen and evaluated technology for two decades. The Betterpath architecture, stack, and scalability is one of the best I have seen to date in healthcare data retrieval,” says Richie Etwaru, CEO of “Matt is a first-class citizen in the new cohort of healthcare data experts; he has learned more over the past four years while getting the technology ready than most of the healthcare venture community combined.” The Betterpath technology core includes Amazon Web Services, React, Datomic, Docker, Cassandra, and Scala wrapped by fax automation, real time APIs, trained Optical Character Recognition, the NPI database, the Unified Medical Language System, and a patented process of medical natural language training and understanding.

With this acquisition adds two patents to its intellectual property portfolio and now operates an IRB approved observational research cohort that enables healthcare’s dark data to be used for FDA regulated clinical trials powering the discovery of transformational medicine.

To access more business news, visit NJB News Now.

Related Articles: